Valence Discovery

Valence Discovery is developing novel algorithms for low-data drug discovery, removing access to data as the principal roadblock when deploying machine learning in pharmaceutical R&D. With an initial focus on cancer and rare diseases, the venture aims to generate, screen, and optimize compounds with up to 1000x less training data than possible using conventional deep learning methods.